Ethiopia Cholera Control and Prevention (ECCP)

Community engagement - Laboratory surveillance - Vaccines Ethiopia active

Project timeline: 01/01/2021 - 31/12/2023

Lead Researcher

Dr. Se Eun Park

Organisation / Institution

International Vaccine Institute

Funders

Korea Support Committee (KSC) for IVI
LG Electronics

Project summary

Cholera remains a public health concern in Ethiopia. We aim to contribute to reducing the burden of cholera and generate scientifically strong data on the effectiveness and impact of OCV (Euvichol-Plus) vaccination in target areas in Ethiopia, as well as various aspects of cholera epidemiology. This includes the disease burden, disease severity and fatality, transmission and carriage/shedding, site-specific risk factors and healthcare seeking behaviour associated with cholera, etiologies of non-cholera diarrheal diseases and antimicrobial resistance, and etc. This project will contribute to the country’s efforts towards the national cholera plan (NCP), with evidence-based data to be generated and stakeholder engagements in alignment with the WHO Global Task Force for Cholera Control (GTFCC) ‘Ending Cholera – Global Roadmap to 2030’.

Co-Investigators

Mekonnen Teferi, Site PI, AHRI
Biruk Yeshitela, AHRI
Moti Edosa, EPHI
Site research team at AHRI and EPHI
Abel Gedefaw, IVI
Dejene Hailu, IVI
Yeonji Jeon, IVI
Ondari Mogeni, IVI
Geun Hyeog Jang, IVI
David Mukasa, IVI
Gideok Pak, IVI
Deok Ryun Kim, IVI

Key Collaborators

Armauer Hansen Research Institute (AHRI)
Ethiopia Public Health Institute (EPHI)